Controversies in the Diagnosis of Type 1 VWD. Paula James MD, FRCPC ISLH Honolulu, Hawaii Friday, May 5, 2017
|
|
- Willis Poole
- 5 years ago
- Views:
Transcription
1 Controversies in the Diagnosis of Type 1 VWD Paula James MD, FRCPC ISLH Honolulu, Hawaii Friday, May 5, 2017
2 Disclosures for Paula James Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific Advisory Board CSL Behring, Bayer, Shire No relevant conflicts of interest to declare No relevant conflicts of interest to declare No relevant conflicts of interest to declare No relevant conflicts of interest to declare CSL Behring, Shire CSL Behring, Shire
3 Dr. Eric von Willebrand first patient described died with her 4 th menstrual period pseudohemophilia
4 House of Hjördis - Föglö
5
6 Von Willebrand Factor synthesized by endothelial cells and megakaryocytes stored in Weibel-Palade bodies (endothelial cells) and alpha granules (platelets) platelet adhesion and aggregation chaperones FVIII
7 Von Willebrand Disease quantitative or qualitative abnormalities of VWF published prevalence ~1 in 100 Rodeghiero, Blood 1987; Werner J Pediatr 1993 symptomatic prevalence ~1 in 1000 Bowman JTH 2010; Bowman Ped Blood and Cancer 2010 autosomal inheritance M=F females diagnosed 2-3:1
8 ISTH Classification Type 1 - mild/moderate quantitative trait ~80% Type 2 - qualitative traits dominant recessive 2A 2B 2M 2N ~20% Type 3 - severe quantitative trait ~ 1 per million Sadler et al JTH 2006
9 Why is Accurate VWD Diagnosis Important? Undiagnosed Affected symptomatic prevalence 1 in 1000 ~ 34,000 Canadians affected far fewer diagnosed symptoms are treatable Diagnosed Unaffected labeled genetic disease exposed to unnecessary/inappropriate treatment unnecessary limitations risk to insurability
10 Controversies in Type 1 VWD Diagnosis 1. Are Bleeding Assessment Tools useful? 2. Should genetic testing be done routinely? 3. What cut-off of VWF should be used?
11 Are BATs useful in the diagnosis of Type 1 VWD?
12 Evolution of Vicenza-Based BATs Vicenza to minutes MCMDM- 1VWD to minutes Condensed MCMDM- 1VWD to minutes PBQ to minutes ISTH BAT to minutes Self-BAT or 0 to minutes
13 Condensed MCMDM-1 VWD Bleeding Questionnaire Epistaxis -- No or trivial ( 5 per year) > 5 per year or more than 10 Consultation only Packing or cauterization or antifibrinolytic Blood transfusion or replacement therapy or desmopressin Cutaneous -- No or trivial ( 1 cm) > 1 cm and no trauma Consultation only Bleeding from minor wounds -- No or trivial ( 5 per year) > 5 per year or more than 5 Consultation only Surgical hemostasis Blood transfusion or replacement therapy or desmopressin Oral cavity -- No Referred, no consultation Consultation only Surgical hemostasis or antifibrinolytic Blood transfusion or replacement therapy or desmopressin Gastrointestinal bleeding -- No Associated with ulcer, portal hypertension, hemorrhoids, angiodysplasia Spontaneous Surgical hemostasis, blood transfusion, replacement therapy, desmopressin, antifibrinolytic -- Tooth extraction No bleeding in at least 2 extractions None done or no bleeding in 1 extraction Reported, no consultation Consultation only Resuturing or packing Blood transfusion or replacement therapy or desmopressin Surgery No bleeding in at least 2 surgeries None done or no bleeding in 1 surgery Reported, no consultation Consultation only Surgical hemostasis or antifibrinolytic Blood transfusion or replacement therapy or desmopressin Menorrhagia -- No Consultation only Antifibrinolytics, oral contraceptive pill use Dilation & curettage, iron therapy, ablation Blood transfusion or replacement therapy or desmopressin or hysterectomy Postpartum hemorrhage No bleeding in at least 2 deliveries None done or no bleeding in 1 delivery Consultation only Dilation & curettage, iron therapy, antifibrinolytics Blood transfusion or replacement therapy or desmopressin Hysterectomy Muscle hematomas -- Never Post trauma, no therapy Spontaneous, no therapy Spontaneous or traumatic, requiring desmopressin or replacement therapy Hemarthrosis -- Never Post trauma, no therapy Spontaneous, no therapy Spontaneous or traumatic, requiring desmopressin or replacement therapy Spontaneous or traumatic, requiring surgical intervention or blood transfusion Spontaneous or traumatic, requiring surgical intervention or blood transfusion Central nervous system bleeding -- Never Subdural, any intervention Intracerebral, any intervention
14 Condensed MCMDM-1 VWD Bleeding Questionnaire Prospectively validated Primary Care Setting, n=217 adults For Type 1 VWD, BS 4 Sensitivity = 100% Specificity = 87% PPV = 0.20 NPV 1.0 LR+ = 7.5 (95% CI ) Bowman et al, JTH 2008
15 Condensed MCMDM-1 VWD Bleeding Questionnaire ROC n=217 AUC p<0.001 Bowman et al, JTH 2008
16
17 BAT Limitations current BATs cannot distinguish one mild bleeding disorder from another are not helpful if the patient has not bled pediatrics males cannot capture changes in bleeding over time cumulative
18 Should genetic testing be routinely performed for the diagnosis of Type 1 VWD?
19 VWF kb genomic sequence 12p13.3 VWF mrna 8.7 kb Ginsburg, Science, 1985; Lynch, Cell, 1985; Sadler, PNAS, 1985; Verweij, EMBO, 1985
20 Type 1 VWD James et al, Blood 2007
21 Sequence variation more common VWF < 0.30 IU/mL Flood et al, Blood 2016
22 Mutation Detection Rydz, Am J Hematol, 2013; Goodeve, JTH, 2015; Yadegari, Thromb Haemost, 2012; James, Blood, 2007; Goodeve, Blood, 2007; Cumming, Thromb Haemost, 2006; Bowman, JTH, 2013; Bogdanova, Hum Mutat, 2007; Johnsen JTH, 2015
23 Influence of other Genetic Loci James et al, Blood 2007
24 Type 1 VWD if genetic variation identified challenge to determine pathogenicity new variants are common multiple variants no worse phenotype contribution of other/novel loci ABO CLEC4M VWF clearance evaluating inheritance within a family challenging variable expressivity incomplete penetrance
25 Highly Heritable Dominant Negative VWF Mutations Low Heritability VWF Mutations missense splicing transcriptional + ABO Blood Group + Other Genetic Modifiers ~35% of cases 0% VWF Level 50%
26 What cut-off of VWF should be used to diagnose Type 1 VWD?
27 Type 1 VWD vs. Low VWF Type 1 VWD Low VWF VWF < 0.30 IU/mL VWF IU/mL Bleeding phenotype? Optimal management? Nichols et al, Haemophilia 2008; Laffan et al, Brit J Haem 2014
28 Bleeding Scores by VWF Level Flood et al, Blood 2016
29 Should we use Low VWF PROS not labelled as disease treat VWF as a risk factor for bleeding CONS lack of recognition of the importance barrier to care
30 Conclusions Are bleeding scores helpful in the diagnosis of Type 1 VWD? YES Should genetic testing be routinely performed for Type 1 VWD diagnosis? NO Should we reserve the diagnosis of Type 1 VWD for those with VWF:Ag < 0.30 IU/mL PROBABLY
31 Acknowledgements Funding:
GUIDELINES. for the diagnosis and management of von Willebrand disease (VWD)
GUIDELINES for the diagnosis and management of von Willebrand disease (VWD) The Canadian Hemophilia Society (CHS) is committed to improve the health and quality of life of all people with inherited bleeding
More informationBLEEDING. Introduction. Starship Children s Health Clinical Guideline. Introduction Bleeding Questionnaire. Scoring Key References
te: The electronic version of this guideline is the version currently in use. Any printed version can Introduction Bleeding Questionnaire Scoring Key References Introduction This bleeding questionnaire
More informationPediatric Bleeding Questionnaire (PBQ)
Date Patient Number Patient Name Gender Male Female Age DOB (dd/mm/yy) Ethnic Background of: Father Mother Presenting complaint of bleeding or bruising today? Ever been diagnosed with a bleeding disorder?
More informationThe Diagnosis of VWD Interpreting laboratory testing for a complex genetic disorder
The Diagnosis of VWD Interpreting laboratory testing for a complex genetic disorder David Lillicrap Department of Pathology and Molecular Medicine Queen's University, Kingston, Canada Bangkok, November
More informationExpanding your Choices: Recent additions to the VWF test menu
Expanding your Choices: Recent additions to the VWF test menu Kenneth Friedman, M.D. Director, Hemostasis Reference Lab BloodCenter of Wisconsin, Milwaukee WI Disclosures for Ken Friedman, M.D. Research
More informationVon Willebrand Disease: Management and Complications. Mike Makris Sheffield, UK
Von Willebrand Disease: Management and Complications Mike Makris Sheffield, UK Disclosures for Mike Makris Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific
More informationEDUCATIONAL QUIZ WITH VOTING ON VWD TOPIC. P. Smejkal Department of Hematology, Masaryk University Hospital Brno, Czech Republic
EDUCATIONAL QUIZ WITH VOTING ON VWD TOPIC P. Smejkal Department of Hematology, Masaryk University Hospital Brno, Czech Republic Classification of von Willebrand disease type 1 partial quantitative deficiency,
More informationGeneration and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease
Journal of Thrombosis and Haemostasis, 6: 2062 2066 DOI: 10.1111/j.1538-7836.2008.03182.x ORIGINAL ARTICLE Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand
More informationApproccio diagnostico al paziente con diatesi emorragica
EVIDENZE NEL TRATTAMENTO DELLE PATOLOGIE TROMBOEMBOLICHE E DELLE PATOLOGIE EMORRAGICHE Varese, 10-11 Marzo 2016 Approccio diagnostico al paziente con diatesi emorragica Alberto Tosetto Centro Malattie
More informationClinical picture of Von Willebrand disease in the Netherlands
Clinical picture of Von Willebrand disease in the Netherlands 20 th Annual Meeting BSTH, Antwerp 22 november 2012 Prof. Dr Frank W.G. Leebeek ErasmusMC Rotterdam The Netherlands Von Willebrand Disease
More informationEasy bruising vs Coagulopathy
Easy bruising vs Coagulopathy Sept. 19, 2015 Lakehead Summer School Chris Hillis, MD MSc FRCPC hillis@hhsc.ca @HemeHillis Aim & Objectives Aim: To increase comfort in detecting non-pathologic bleeding
More informationManagement of HMB in women with haematological disease and other medical disorders. Rezan A Kadir The Royal Free Foundation Trust IfWH, UCL
Management of HMB in women with haematological disease and other medical disorders Rezan A Kadir The Royal Free Foundation Trust IfWH, UCL HMB - Systemic causes FIGO Classification - PALM-COEIN COEIN-
More informationvon Willebrand Disease
von Willebrand Disease Jeremy Robertson Paediatric Haematologist Royal Children s s Hospital & Pathology Queensland Foglo,, April 1924: the journey begins Oskar and Augusta sail to Helsinki... ...to o
More informationIntroduction to von Willebrand Disease Mary Lesh RN, MS, CPNP
Introduction to von Willebrand Disease Mary Lesh RN, MS, CPNP OVERVIEW Von Willebrand Disease (VWD) is the most common hereditary bleeding disorder in humans, with an estimated prevalence ranging upward
More informationCongenital bleeding disorders
Congenital bleeding disorders Overview Factor VIII von Willebrand Factor Complex factor VIII von Willebrand factor (vwf) complex circulate as a complex + factor IX intrinsic pathway Platelets bind via
More informationVon Willebrand Disease. Alison Street Malaysia April 2010
Von Willebrand Disease Alison Street Malaysia April 2010 Physiology of VWF OUTLINE Clinical presentation of VWD Classification of VWD with emphases on Type 1, 2B and 2N disease Testing for VWD Treatment
More informationProspective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation
Journal of Thrombosis and Haemostasis, 9: 8 DOI:./j.58-786..65.x ORIGINAL ARTICLE Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic
More informationGeneration and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease
Journal of Thrombosis and Haemostasis, 6: 2062 2066 DOI: 10.1111/j.1538-7836.2008.03182.x ORIGINAL ARTICLE Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand
More informationNew insights into genotype and phenotype of VWD
THERAPEUTIC PROGRESS IN VON WILLEBRAND DISEASE New insights into genotype and phenotype of VWD Veronica H. Flood 1 1 Division of Pediatric Hematology/Oncology, Department of Pediatrics, Medical College
More informationDiagnosis of Inherited von Willebrand Disease: A Clinical Perspective
Diagnosis of Inherited von Willebrand Disease: A Clinical Perspective Augusto B. Federici, M.D. 1 ABSTRACT von Willebrand disease (VWD) is the most frequent inherited disorder of hemostasis and is due
More informationAcquired Inhibitors of Coagulation
Acquired Inhibitors of Coagulation Christine L Kempton, MD, MSc Emory University Disclosures for In compliance with COI policy, ISTH requires the following disclosures to the session audience: Research
More informationDiagnosis and Management of Von Willebrand Disease
CLINICAL VIGNETTE Diagnosis and Management of Von Willebrand Disease Olga Olevsky, M.D. and Stephen Wong, M.D. Von Willebrand s Disease is the most common inherited bleeding disorder. Low levels of Von
More informationVon Willebrand s disease is an inherited bleeding disorder
The new england journal of medicine Review Article Dan L. Longo, M.D., Editor Von Willebrand s Disease Frank W.G. Leebeek, M.D., Ph.D., and Jeroen C.J. Eikenboom, M.D., Ph.D. Von Willebrand s disease is
More informationTREATMENT & MANAGEMENT OF VON WILLEBRAND DISEASE
TREATMENT & MANAGEMENT OF VON WILLEBRAND DISEASE Dr Susan Russell Director HTC Sydney Children s Hospital, Randwick HFA Meeting 2015 What is von Willebrand Factor? VWF is a large multimeric protein Two
More informationThe evolution and value of bleeding assessment tools
Journal of Thrombosis and Haemostasis, 10: 2223 2229 DOI: 10.1111/j.1538-7836.2012.04923.x REVIEW ARTICLE The evolution and value of bleeding assessment tools NATALIA RYDZ* and PAULA D. JAMES *Department
More informationSymptomatic VWD in a Pediatric Population- a guide to administering the Bleeding Questionnaire
Symptomatic VWD in a Pediatric Population- a guide to administering the Bleeding Questionnaire General Points May 03, 2010 1. This questionnaire has been designed to be administered by a health professional
More informationCurrent issues in diagnosis and treatment of von Willebrand disease
Received: 18 September 2017 Accepted: 7 November 2017 DOI: 10.1002/rth2.12064 REVIEW ARTICLE Current issues in diagnosis and treatment of von Willebrand disease Daniel A. Keesler 1,2,3 Veronica H. Flood
More informationAcquired Von Willebrand Syndrome and Heyde s Syndrome. Debra L. Smith, MD, PhD Hematology Fellows Conference April 8, 2016
Acquired Von Willebrand Syndrome and Heyde s Syndrome Debra L. Smith, MD, PhD Hematology Fellows Conference April 8, 2016 Objectives Describe acquired von Willebrand syndrome (AVWS) clinical presentation
More informationNew treatment approaches to von Willebrand disease
VON WILLEBRAND DISEASE: REDISCOVERING AN OLD DISEASE New treatment approaches to von Willebrand disease Michelle Lavin 1 and James S. O Donnell 1,2,3 1 Haemostasis Research Group, Institute of Molecular
More informationBleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph
Bleeding Disorders Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Normal hemostasis The normal hemostatic response involves interactions among: The blood vessel wall (endothelium)
More informationApproach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate
Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:
More informationPlatelet Disorders. By : Saja Al-Oran
Platelet Disorders By : Saja Al-Oran Introduction The platelet arise from the fragmentation of the cytoplasm of megakaryocyte in the bone marrow. circulate in the blood as disc-shaped anucleate particles
More informationLaboratory Diagnosis and Management of Von Willebrand Disease in South Africa
Laboratory Diagnosis and Management of Von Willebrand Disease in South Africa Muriel Meiring, Ph.D., 1 Marius Coetzee, M.Med., 1 Mareli Kelderman, D.M.T., 1 and Philip Badenhorst, M.D. 1 ABSTRACT Patients
More informationTHE BASIC SCIENCE, DIAGNOSIS, AND CLINICAL MANAGEMENT OF VON WILLEBRAND DISEASE
TREATMENT OF HEMOPHILIA APRIL 2008 NO 35 THE BASIC SCIENCE, DIAGNOSIS, AND CLINICAL MANAGEMENT OF VON WILLEBRAND DISEASE Second Edition David Lillicrap Queen s University Ontario, Canada Published by the
More informationBleeding disorders. Hemostatic failure: Inappropriate and excessive bleeding either spontaneous or in response to injury.
1 Bleeding disorders Objectives: 1. Discuss briefly the physiology of hemostasis. 2. Define the mechanisms of thrombocytopenia and the relative bleeding risk at any given platelet count. 3. Be able to
More informationHemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures
Hemostasis PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures Disorders of Hemostasis - Hemophilia - von Willebrand Disease HEMOPHILIA A defect in the thrombin propagation phase
More informationDiagnosing von Willebrand disease: genetic analysis
VON WILLEBRAND DISEASE: REDISCOVERING AN OLD DISEASE Diagnosing von Willebrand disease: genetic analysis Anne Goodeve Haemostasis Research Group, Department of Infection, Immunity and Cardiovascular Disease,
More informationThe Clinical Features of Chinese Children with von Willebrand Disease: The Experience of a Tertiary Institute
HK J Paediatr (new series) 2011;16:95-100 The Clinical Features of Chinese Children with von Willebrand Disease: The Experience of a Tertiary Institute ZQ ZHANG, GCF CHAN, CCK LAM, JCC SO, DKL CHEUK, AKS
More informationWhat have we learned from large population studies of von Willebrand disease?
VON WILLEBRAND DISEASE: REDISCOVERING AN OLD DISEASE What have we learned from large population studies of von Willebrand disease? Robert R. Montgomery and Veronica H. Flood Blood Research Institute, BloodCenter
More informationGenetic Counselling in relation to genetic testing
Genetic Counselling in relation to genetic testing Dr Julie Vogt Consultant Geneticist West Midlands Regional Genetics Service September 2016 Disclosures for Research Support/P.I. Employee Consultant Major
More informationvon Willebrand Disease: Approach to Diagnosis and Management
hematology Board Review Manual Statement of Editorial Purpose The Hospital Physician Hematology Board Review Manual is a study guide for fellows and practicing physicians preparing for board examinations
More informationAnna M. Randi MD PhD. Imperial College London UK. Von Willebrand factor regulation of angiogenesis: basic mechanisms and implications for disease
Anna M. Randi MD PhD Imperial College London UK Von Willebrand factor regulation of angiogenesis: basic mechanisms and implications for disease Von Willebrand Disease 1926: Finnish physician Erick von
More informationCase Studies: Congenital Platelet Disorders
Case Studies: Congenital Platelet Disorders Presented to Atlanta Wednesday, November 2, 2016 Disclosures for Michele P. Lambert, MD, MTR In compliance with COI policy, ISTH requires the following disclosures
More informationCommon bleeding disorders affecting individuals with Hereditary Hemorrhagic Telangiectasia
TRAINEE SECTION Jennifer LaBranche, BSc 1,2,4 Susan Nahirniak, MD, FRCPC 3 Dilini Vethanayagam, MD, FRCPC 1,4 1University of Alberta - Department of Medicine 2University of Alberta - Department of Biological
More informationDiagnosis of mild bleeding disorders
Review article: Current opinion Peer reviewed article SWISS MED WKLY 2009;139(23 24):327 332 www.smw.ch 327 Diagnosis of mild bleeding disorders Philippe de Moerloose, Emmanuel Levrat, Pierre Fontana,
More informationPeer Review Report #1. Desmopressin. (1) Does the application adequately address the issue of the public health need for the medicine?
20 th Expert Committee on Selection and Use of Essential Medicines Peer Review Report #1 Desmopressin (1) Does the application adequately address the issue of the public health need for the medicine? Desmopressin
More informationVon Willebrand disease (vwd) is the most common
Breast Augmentation in the Patient With von Willebrand Disease The authors describe breast augmentation in a patient with von Willebrand disease (vwd), providing a template for treating such patients.
More informationCome misuro la gravità del sintomo emorragico
VII Giornate Ematologiche Vicen8ne Vicenza, 10-12 O@obre 2016 Come misuro la gravità del sintomo emorragico Bleeding disorders are heterogeneous Mild Bleeding Disorders: Bleeding symptoms reduce QoL, but
More informationThe HEMORR 2 HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in anticoagulated atrial fibrillation patients : The AMADEUS study
The HEMORR 2 HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in anticoagulated atrial fibrillation patients : The AMADEUS study Apostolakis S 1, Lane DA 1, Buller H 2, Lip GY 1 1 University
More informationCatherine P. M. Hayward, MD PhD FRCPC Professor, Pathology & Molecular Medicine, & Medicine, McMaster University Head, Coagulation, Hamilton Regional
Catherine P. M. Hayward, MD PhD FRCPC Professor, Pathology & Molecular Medicine, & Medicine, McMaster University Head, Coagulation, Hamilton Regional Laboratory Medicine Program No relevant disclosures
More informationVon Willebrand Disease
SURGERY AND Von Willebrand Disease Jodi B Farmer, ast editor Von WILLebrand A FaTHer OF MedICIne Erik von Willebrand was born in Vaasa, Finland, on February 1, 1870, to a district engineer and his wife.
More informationGUIDELINE: ASSESSMENT OF BRUISING & BLEEDING IN CHILDREN. All children in whom there is concern regarding bruising / bleeding
GUIDELINE: ASSESSMENT OF BRUISING & BLEEDING IN CHILDREN Reference: Bruising / Bleeding / NAI Version No: 1 Applicable to All children in whom there is concern regarding bruising / bleeding Classification
More informationWhat are InherIted platelet FunCtIon disorders?
What are InherIted platelet FunCtIon disorders? Published by the World Federation of Hemophilia (WFH) World Federation of Hemophilia, 2010 This publication was developed by the WFH and reviewed by Dr.
More informationRoutine preoperative coagulation tests: are they necessary?
Routine preoperative coagulation tests: are they necessary? Dr Azzah Alzahrani MD Pediatrics Hematology /Oncology PSMMS Outline Introduction. Brief review of hemostatic mechanisms. A clinical aspect of
More informationVon Willebrand Disease: Mutations, Von Willebrand Factor Variance and Genetic Drift
Von Willebrand Disease: Mutations, Von Willebrand Factor Variance and Genetic Drift Student: Cecilia Carlsson Pecharromán Supervisor: Torbjörn Säll Institution: Department of Biology, Lund University E-mail:
More informationType 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality
478 Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality Giancarlo Castaman, MD 1 Augusto B. Federici, MD 2 1 Center for Bleeding Disorders, Department of Heart and Vessels, Careggi
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationDiagnosis and management of von Willebrand disease in Australia
Review Article Page 1 of 13 Diagnosis and management of von Willebrand disease in Australia Emmanuel J. Favaloro 1,2, Leonardo Pasalic 1,2, Jennifer Curnow 2,3 1 Laboratory Haematology, Institute of Clinical
More informationImproving Patient Outcomes in the Management of Hemophilia. Disclosures
Improving Patient Outcomes in the Management of Hemophilia Mark T. Reding, MD Associate Professor of Medicine Division of Hematology, Oncology, and Transplantation Director, Center for Bleeding and Clotting
More informationType 2M and Type 2A von Willebrand Disease: Similar but Different
483 Type 2M and Type 2A von Willebrand Disease: Similar but Different Emmanuel J. Favaloro, PhD, FFSc (RCPA) 1,2 Leonardo Pasalic, MBBS, FRACP, FRCPA 1,2 Jennifer Curnow, MBBS, FRACP, FRCPA, PhD 1 1 Departments
More informationTXA: NOT JUST A ONE TRICK PONY TERRY MCGOVERN DO, MPH VITUITY, ST JOHN S REGIONAL MEDICAL CENTER, OXNARD, CA
TXA: NOT JUST A ONE TRICK PONY TERRY MCGOVERN DO, MPH VITUITY, ST JOHN S REGIONAL MEDICAL CENTER, OXNARD, CA DISCLOSURES I have no relevant financial relationships with the manufacturer(s) of any commercial
More informationGastrointestinal angiodysplasia and bleeding in von Willebrand disease
Review Article 427 Gastrointestinal angiodysplasia and bleeding in von Willebrand disease Massimo Franchini 1 ; Pier Mannuccio Mannucci 2 1 Department of Transfusion Medicine and Hematology, Carlo Poma
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationCOAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)
COAGULATIONS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin) Haemostasis-blood must be maintained in a fluid state in order to function as a transport system, but must be able to solidify to form a clot following
More informationVON WILLEBRAND DISEASE
VON WILLEBRAND DISEASE A Discussion for Clinicians 2016 Carol K. Kasper, M.D. Emerita Professor of Medicine, University of Southern California; Emerita Director, Orthopaedic Hemophilia Treatment Center
More informationNadine Ajzenberg** Marie-Genevieve Huisse** Isabelle Mahé*** Edith Peynaud **** Aurelie Roche* Patricia Esselin* Laurence Auguste-Charlery*
«new oral anticoagulants and brain specificity» Claire Bal dit Sollier * Ariane Davout * Sun-Young Park* Irène Clavijo* Adeline-Zoe Thoux * Ioana Muller* Ludovic Drouet* Nadine Ajzenberg** Marie-Genevieve
More informationCitation for published version (APA): Verschueren, S. (2017). Systemic causes of heavy menstrual bleeding [Groningen]: Rijksuniversiteit Groningen
University of Groningen Systemic causes of heavy menstrual bleeding Verschueren, Sophie IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
More informationINVESTIGATING THE GENETIC BASIS OF TYPE 3 OF VON WILLEBRAND DISEASE (VWD)
INVESTIGATING THE GENETIC BASIS OF TYPE 3 OF VON WILLEBRAND DISEASE (VWD) by Mackenzie Leigh Bowman A thesis submitted to the Department of Pathology and Molecular Medicine In conformity with the requirements
More informationIntroduction. menorrhagia, platelet disorder, von Willebrand disease, von Willebrand factor
Haemophilia (2008), 14, 171 232 DOI: 10.1111/j.1365-2516.2007.01643.x GUIDELINES von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute
More informationVon Willebrand Disease An Inherited Bleeding Disorder
Von Willebrand Disease An Inherited Bleeding Disorder Bleeding disorders are not common in dogs and cats. Yet when they occur, they can be life-threatening. One inherited bleeding disorder is called von
More informationApproach to bleeding
Approach to bleeding By Assoc. Prof. Darintr Sosothikul, MD Pediatric Hematology-Oncology division, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University The mechanism of
More informationReport on von Willebrand Disease in Malaysia
ID Design 2012/DOOEL Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. 2016 Mar 15; 4(1):112-117. http://dx.doi.org/10.3889/oamjms.2016.030 eissn: 1857-9655 Clinical Science
More informationManagement of Inherited Von Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients
Management of Inherited Von Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients Augusto B. Federici, M.D., 1,2 Paolo Bucciarelli, M.D., 2 Giancarlo Castaman, M.D., 3 Luciano
More informationDr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN
Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets
More informationBLEEDING (PLATELET) DISORDER. IAP UG Teaching slides
BLEEDING (PLATELET) DISORDER 1 APPROACH The initial set of questions should establish the following: (1) the most common site and type of bleeding (e.g., mucocutaneous versus articular or deep muscle),
More informationRare Bleeding Disorders
Rare Bleeding Disorders Item type Authors Publisher Other Irish Haemophilia Society (IHS) Irish Haemophilia Society (IHS) Downloaded 20-Jun-2018 06:21:18 Link to item http://hdl.handle.net/10147/575445
More informationArthropathy after joint bleeding in patients with Von Willebrand disease
REVIEW HEMATOLOGY 253 Arthropathy after joint bleeding in patients with Von Willebrand disease K.P.M. van Galen, MD, MSc, E.P. Mauser-Bunschoten, MD, PhD SUMMARY Von Willebrand disease is the most common
More informationEvaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding
FROM THE AMERICAN ACADEMY OF PEDIATRICS TECHNICAL REPORT Evaluating for Suspected Child Abuse: Conditions That Predispose to Bleeding Shannon L. Carpenter, MD, MS, Thomas C. Abshire, MD, James D. Anderst,
More informationSession 1 : Fibrinogen deficiencies
13 th Workshop on Thrombosis and Paediatric Haemostasis Marseille, 13 th October 2010 Session 1 : Fibrinogen deficiencies Clinical, biological and therapeutic concerns : P De Moerloose, Geneva Genetic
More informationASH Special Educational Symposium
ASH Special Educational Symposium Session Chair: Vincent J. Picozzi, MD, MMM Speakers: Andra H. James, MD, MPH; Margaret V. Ragni, MD, MPH; and Vincent J. Picozzi, MD, MMM Bleeding Disorders in Premenopausal
More informationDr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College
Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction
More informationThis is a repository copy of von Willebrand's disease: a report from a meeting in the Åland islands.
This is a repository copy of von Willebrand's disease: a report from a meeting in the Åland islands. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/110846/ Version: Accepted
More informationReview Series. Diagnostic approach to von Willebrand disease INHERITED BLEEDING DISORDERS. Introduction. Screening evaluation for VWD
Review Series From www.bloodjournal.org by guest on October 21, 2018. For personal use only. INHERITED BLEEDING DISORDERS Diagnostic approach to von Willebrand disease Christopher Ng, 1,2 David G. Motto,
More informationIn 1926, Finnish physician Erik von Willebrand
von Willebrand Disease and Cardiopulmonary Bypass: A Case Report Oxana L. Teppone-Martin, CRNA, MS Manxu Zhao, MD, MS Teresa E. Norris, CRNA, EdD The anesthetic management of patients undergoing cardiac
More informationA diagnostic approach to mild bleeding disorders
Journal of Thrombosis and Haemostasis, 14: 1507 1516 DOI: 10.1111/jth.13368 REVIEW ARTICLE A diagnostic approach to mild bleeding disorders J. BOENDER, M. J. H. A. KRUIP and F. W. G. LEEBEEK Department
More informationPreface to Special Issue: diagnosis and management of von Willebrand disease diverse approaches to a global and common bleeding disorder
Preface Page 1 of 7 Preface to Special Issue: diagnosis and management of von Willebrand disease diverse approaches to a global and common bleeding disorder It is a pleasure to present the readership of
More informationVon Willebrand Disease in the Netherlands from genetic variation to phenotypic variability. Yvonne Veroni Sanders
Von Willebrand Disease in the Netherlands from genetic variation to phenotypic variability Yvonne Veroni Sanders Von Willebrand Disease in the Netherlands from genetic variation to phenotypic variability
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationVWF other roles than hemostasis. Summary 1: VWF & hemostasis synthesis 11/4/16. Structure/function relationship & functions kDa.
VWF other roles than hemostasis Len$ng PJ, Casari C et al JTH 2012 Summary 1: VWF & hemostasis synthesis Structure/function relationship & functions (HMWM) 20.000kDa multimerization propeptide FVIII GPIb
More informationVon Willebrand disease type 1: a diagnosis in search of a disease
Perspective Von Willebrand disease type 1: a diagnosis in search of a disease J. Evan Sadler Introduction Von Willebrand disease (VWD) type 1 is reported to be common but frequently is difficult to diagnose.
More informationVALIDATION OF THE ISTH/SSC BLEEDING ASSESSMENT TOOL FOR INHERITED PLATELET DISORDERS
VALIDATION OF THE ISTH/SSC BLEEDING ASSESSMENT TOOL FOR INHERITED PLATELET DISORDERS A study project by the SSC Platelet Physiology Subcommittee Coordinator: Paolo Gresele. Department of Medicine, Section
More informationGLANZMANN S THROMBASTHENIA. Stacey Shiovitz January 13, 2012
GLANZMANN S THROMBASTHENIA Stacey Shiovitz January 13, 2012 HELP!! MY PATIENTHASGT DO YOU EVEN KNOW WHAT THAT IS? CASE 27yo woman presented tdto gynecology clinic i for menorrhagia x 10 days Bleeding started
More informationEDUCATIONAL COMMENTARY PLATELET DISORDERS
EDUCATIONAL COMMENTARY PLATELET DISORDERS Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn
More informationBleeding Disorders: (Hemorrhagic Diatheses) Tests used to evaluate different aspects of hemostasis are the following:
Bleeding Disorders: (Hemorrhagic Diatheses) Excessive bleeding can result from: 1. Increased fragility of vessels. 2. Platelet deficiency or dysfunction. 3. Derangement of coagulation. 4. Combinations
More informationTreatment of von Willebrand disease. Jenny Goudemand Haematology Department University Hospital of Lille - France
Treatment of von Willebrand disease Jenny Goudemand Haematology Department University Hospital of Lille - France French registries on VWD Inclusion criteria FranceCoag Network French Institute for Public
More informationBleeding history Recommendations of the working group on Perioperative Coagulation of the ÖGARI Gaps in the standard coagulation tests
Bleeding history Recommendations of the working group on Perioperative Coagulation of the ÖGARI modified from the publication in: Anaesthesist 2007; 56: 604-11 The aim of the preoperative clarification
More informationSysmex Educational Enhancement and Development No
SEED Coagulation Sysmex Educational Enhancement and Development No 2 2016 An approach to the bleeding patient The purpose of this newsletter is to provide an overview of the approach to the bleeding patient
More informationSession II New Developments in the Classification and Diagnosis of VWD. Phenotypic classification of von Willebrand disease
Session II New Developments in the Classification and Diagnosis of VWD Phenotypic classification of von Willebrand disease [haematologica reports] 2005;1(4):9-15 ULRICH BUDDE From the Coagulation Laboratory,
More informationDevelopments in the diagnostic procedures for von Willebrand disease
Journal of Thrombosis and Haemostasis, 14: 449 460 DOI: 10.1111/jth.13243 REVIEW ARTICLE Developments in the diagnostic procedures for von Willebrand disease A. DE JONG and J. EIKENBOOM Department of Thrombosis
More information